NCT02729168View on ClinicalTrials.gov

Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Rabies
Interventions
BIOLOGICAL

Human rabies vaccine

Trial Locations (1)

Unknown

Cho Gao Health Centre, Chợ Gạo

All Listed Sponsors
collaborator

Bharat Biotech International Limited

INDUSTRY

lead

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products

OTHER

NCT02729168 - Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly | Biotech Hunter | Biotech Hunter